Search

Displaying results 2881 - 2890 of 10000 in total
  1. Drug

    Icotinib

    go.drugbank.com/drugs/DB11737
    Investigational

    . was given a “May Proceed” from the US FDA to conduct a Phase I study for the evaluation of icotinib as a treatment of EGFR+ Non-Small Cell Lung Cancer (NSCLC). … Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Icotinib was approved in China by the SFDA in June, 2011 and in January 2014, Beta Pharma, Inc

  2. Drug

    Lapatinib

    go.drugbank.com/drugs/DB01259
    ApprovedInvestigational

    Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. … It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine.

    Synonyms: N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
  3. Drug

    Moroctocog alfa

    go.drugbank.com/drugs/DB13999
    Approved

    Moroctocog alfa is identical in sequence to endogenously produced Factor VIII, but does not contain the B-domain, which has no known biological function. … As it does not contain von Willebrand factor it is not indicated in von Willebrand’s disease [L41170].

  4. Drug

    Phenylbutazone

    go.drugbank.com/drugs/DB00812
    ApprovedVet approvedWithdrawn

    Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822)

    Categories: Anti-Inflammatory Agents, Non-Steroidal (Non-Selective), Analgesics, Non-NarcoticSynonyms: 3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine, 4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione
  5. Indication

    ALK positive Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0167962
    Drugs: Alectinib
    Synonyms: ALK Positive Non-small Cell Lung Cancer, ALK-positive Non-small Cell Lung Cancer
  6. Indication

    Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    go.drugbank.com/conditions/DBCOND0080506
    Drugs: Polatuzumab vedotin
    Synonyms: Diffuse large B-cell lymphoma NOS, Diffuse Large B-Cell Lymphoma (DLBCL), Nos
  7. Indication

    HER2-positive Metastatic Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0173515
    Drugs: Zongertinib
    Synonyms: HER2-positive Metastatic Non-Small Cell Lung Cancer
  8. Indication

    Squamous Cell Cancer Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0059210
    Drugs: Tislelizumab
    Synonyms: Lung Non-Small Cell Squamous Carcinoma, Non-Small Cell Squamous Lung Cancer
  9. Indication

    Stage IIIA Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173421
    Drugs: Pembrolizumab
    Synonyms: Stage IIIA Non-Small Cell Lung Cancer (NSCLC)
  10. Indication

    Stage IV Non-small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0122752
    Drugs: Gemcitabine
    Synonyms: Non-Small Cell Lung Cancer Stage IV, Stage 4 Non-small cell lung cancer